Keywords: first, launch, teva, copaxone, multiple, sclerosis, forecast

First Launch Of Teva's Copaxone For Multiple Sclerosis

Article | 06 January 1997

Print This

As forecast, Teva's novel drug treatment for multiple sclerosis Copaxone(glatiramer acetate for injection) has been launched in its first ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in